Showing results (341-350 of 381) with videos related to

Sort By:
Pageof 39
Nature Communications|August 22, 2025
Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancerHanshen Yang, Xiaozhen Zhang, Sirui Zhang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 29, 2023
Targeting leucine-rich repeat serine/threonine-protein kinase 2 sensitizes pancreatic ductal adenocarcinoma to anti-PD-L1 immunotherapyKang Sun, Xiaozhen Zhang, Mengyi Lao, et al.
Science Advances|June 22, 2022
Liver cancer heterogeneity modeled by in situ genome editing of hepatocytesMei Tang, Yang Zhao, Jianhui Zhao, et al.
Elife|May 14, 2021
A subcellular map of the human kinomeHaitao Zhang, Xiaolei Cao, Mei Tang, et al.
Cancer Letters|January 25, 2024
Optimizing hepatocellular carcinoma disease staging systems by incorporating tumor micronecrosis: A multi-institutional retrospective studyYangyang Wang, Xu Sun, Cao Chen, et al.
Biotechnology Journal|August 11, 2021
Cross-neutralization of RBD mutant strains of SARS-CoV-2 by convalescent patient derived antibodiesYan Lou, Wenxiang Zhao, Haitao Wei, et al.
The Journal of Infectious Diseases|June 1, 2020
Decreased B Cells on Admission Associated With Prolonged Viral RNA Shedding From the Respiratory Tract in Coronavirus Disease 2019: A Case-Control StudyShaorui Hao, Jiangshan Lian, Yingfeng Lu, et al.
Molecular Cell|August 28, 2021
Induced phase separation of mutant NF2 imprisons the cGAS-STING machinery to abrogate antitumor immunityFansen Meng, Zhengyang Yu, Dan Zhang, et al.
Hepatology (Baltimore, Md.)|October 31, 2025
Satellite lesions versus intrahepatic metastasis in multifocal intrahepatic cholangiocarcinoma: Prognostic impact and genomic profilingTao Wei, Zhi-Jie Ma, Shouliang Guo, et al.
Advances in Therapy|May 23, 2026
First-Line Pembrolizumab Plus Chemotherapy for Advanced Biliary Tract Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-966 StudyZhenggang Ren, Tingbo Liang, Shanzhi Gu, et al.
Pageof 39